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fluids. However, this difference decreases progressively duringEffect of dwell time on carbonyl stress using icodextrin and
dwell time, mainly as a result of the influx of total RCOs.amino acid peritoneal dialysis fluids.
Background. Deterioration of the peritoneal membrane
limits the technical survival of peritoneal dialysis (PD). Ad-
vanced glycation of the membrane has been incriminated in this Progressive deterioration of the peritoneal membrane
evolution. Advanced glycation end products (AGEs) develop permeability limits the technical survival of peritoneal
under the influence of glucose and of its degradation products,
dialysis (PD) [1]. The high-glucose content of the PDmainly reactive carbonyl compounds (RCOs) such as glyoxal
fluid has been incriminated in its pathogenesis [2]. Heat(GO), methylglyoxal (MGO), and 3-deoxyglucosone (3-DG).
sterilization of PD fluids degrades glucose into a varietyThe present study was undertaken to evaluate the impact of
recently developed glucose-free PD fluids on AGE generation. of reactive carbonyl compounds (RCOs), such as meth-
Methods. Recently developed glucose-free PD fluids con- ylglyoxal (MGO), glyoxal (GO), and 3-deoxyglucosone
taining either icodextrin or amino acids were investigated. GO, (3-DG) [3, 4], all of which generate advanced glycationMGO, and 3-DG [high-performance liquid chromatography
end products (AGEs) [5–8], implicated in structural and(HPLC)] and total RCOs (spectrophotometry) were measured
functional alterations of matrix and cellular proteinsin fresh solutions and in effluents after various dwell duration.
[9–11]. AGEs, Ne-carboxymethyllysine (CML), and pen-The AGE formation potential of PD fluids and effluents was
assessed by incubation at 378C, for one week, with bovine tosidine have been identified in the peritoneal membrane
serum albumin and by the eventual measurement of pentosi- of long-term PD patients [2, 12], and their accumulation
dine (HPLC) and Ne-carboxymethyllysine (CML; gas chroma- has been associated with alterations of membrane per-tography/mass spectrometry).
meability [2, 13–15].Results. GO, MGO, and 3-DG (P , 0.001) as well as total
The recent development of glucose-free dialysatesRCOs levels (P , 0.01) were significantly lower in icodextrin
containing either icodextrin or amino acids [16–18] hasand amino acid PD fluid than in commercial, heat-sterilized,
1.36% glucose PD fluid. Pentosidine and CML generation were raised the hope that their use might prevent or retard the
also significantly lower (P , 0.001) in icodextrin and amino degradation of the peritoneal membrane. In the present
acid PD fluid than in conventional 1.36% glucose PD fluid. study, we evaluated icodextrin and amino acid dialysates,The levels of total RCOs, however, increased in icodextrin and
either fresh or after various dwell durations. Their GO,amino acid PD fluid effluents with dwell time. AGE formation
MGO, 3-DG, and total RCOs contents as well as their inpotential rose accordingly, as demonstrated by a parallel in-
vitro AGE generation potential (pentosidine and CML)crease in the generation of pentosidine and CML during incu-
bation of PD effluents. were assessed. Although both fresh, glucose-free dialy-
Conclusion. The present data demonstrate lower RCO con- sates had markedly lower levels of RCOs than commer-
tents and AGE formation potential in fresh icodextrin and cial heat-sterilized, 1.36% glucose PD fluid, this differ-
amino acid PD fluids than in fresh heat-sterilized glucose PD
ence was altered with dwell duration. Similarly, the lower
capacity to generate AGEs in vitro present in fresh glu-
cose-free dialysates faded during prolonged dwell.Key words: peritoneal dialysis fluids, glucose degradation product, ad-
vanced glycation end product, reactive carbonyl compound, biocom-
patibility.
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Healthcare, Round Lake, IL, USA), icodextrin (Ex- curve between DNPH concentration and absorbance
[19]. In this method, the glucose-derived carbonyl grouptraneale; Baxter Healthcare), or amino acid (Nutri-
neale; Baxter Healthcare) were used. To determine the also reacts with DNPH. The glucose-derived carbonyl
content in samples (PD fluids, PD effluents, and plasma)effect of heat sterilization, PD fluid identical to Dianeale
PD-4 (1.36% glucose) was prepared and sterilized with were therefore calculated on the basis of the glucose
concentration of samples and a standard curve of thea 0.22 mm pore filter.
carbonyl content obtained in distilled water containing
Patients various concentrations of glucose. The level of RCOs
other than glucose, hereafter referred to as total RCOs,Six patients (4 males) with a mean age of 62.9 years
(range 46 to 73) were included. They had been on PD was then calculated as the difference between total PD
sample carbonyl and glucose-derived carbonyl level. Itfor an average of 26 months (range 23 to 73). They used
one bag daily of either icodextrin (N 5 3) or amino acids should be pointed out that unlike HPLC data, DNPH
results are obtained without standards. The several ex-(N 5 3). Specimen for analysis was obtained preinfusion
and at time 0, 2, 4, and 6 hours postinfusion for icodextrin traction steps probably reduce their concentration to an
unknown extent. Thus, DNPH results cannot be com-and amino acids and 12 hours postinfusion for icodextrin
only. pared on a molar basis with the specific RCOs measured
by HPLC. Furthermore, they can be compared only
HPLC analysis of MGO, GO, and 3-DG among samples analyzed simultaneously with the same
rigorously followed methodology, as was the case in theHigh-performance liquid chromatography (HPLC) was
used to identify and quantitate three RCOs for which present studies.
pure standards are available, that is, MGO, GO, and
In vitro incubation experiments3-DG [12]. The standards were used for calibration pur-
poses. Two hundred microliters of 0.025% 2,4-dinitro- Peritoneal dialysis fluids were fortified with fatty acid-
free bovine serum albumin (BSA; Sigma) to the finalphenylhydrazine (DNPH) in 0.5 N HCl were added to
200 mL of plasma ultrafiltrates or PD effluent ultrafil- concentration of 30 mg/mL. BSA had been dissolved in
0.1 mol/L phosphate buffer (pH 7.4). They were steri-trates. After standing at 308C for 30 minutes in the dark,
20 mL of 1 mol/L acetone were added to react with excess lized with a 0.22 mm pore filter and incubated under air
in sealed sterile 1.5 mL plastic tubes at 378C for oneDNPH at 308C for 10 minutes in the dark. The mixture
was washed three times with 200 mL of hexane, and the week. In some experiments, incubation was performed
in the presence of 50 mmol/L aminoguanidine (Tokyoremaining aqueous layer was extracted with 200 mL of
octanol. The octanol extract was diluted with acetoni- Chemical Industry, Tokyo, Japan) [20] or OPB-9195 [(6)-
2-isopropylidenehydrazono-4-oxo-thlazolidin-5-ylaceta-trile, and hydrazone derivatives were analyzed by re-
verse-phase HPLC, using a Waters Purecil C18 column nilide] (a gift from Fujii Memorial Research Institute,
Otsuka Pharmaceutical, Ohtsu, Japan) [19, 21]. The pH(5 mm, 4.6 3 250 mm) with an absorbance detection at
360 nm. The buffer gradient used for elution was 15 to did not change during incubation, with its value ranging
from 7.0 to 7.5. Each experiment was performed in dupli-100% buffer B (85% to 0% buffer A) during 50 minutes
(buffer A, 0.08% trifluoroacetic acid; buffer B, 80% ace- cate. In order to reduce interassay variability, all determi-
nations of one incubation experiment were performedtonitrile containing 0.1% trifluoroacetic acid).
simultaneously in one batch.
Total RCO measurement
Measurement of CML and pentosidineThe number of RCOs far exceeded the three moieties
(GO, MGO, and 3-DG) identified by HPLC. In the ab- For quantitation of CML, samples (100 mL) were di-
luted with 100 mL 0.2 mol/L sodium borate, pH 9.1,sence of adequate standards, spectrophotometry was
used to quantitate the total RCOs. Two hundred micro- followed by addition of 20 mL 1 mol/L NaBH4 in 0.1 N
NaOH. Reduction was carried out for four hours at roomliters of 0.025% DNPH in 0.5 N HCl were added to 200
mL of plasma ultrafiltrates or PD effluent ultrafiltrates. temperature and then protein was precipitated by addi-
tion of an equal volume of 20% trichloroacetic acid.After standing at 308C for 30 minutes in the dark, 20 mL
of 1 mol/L acetone were added to react with excess Protein was pelleted by centrifugation at 2000 3 g for
five minutes. The supernatant was discarded, and theDNPH at 308C for 10 minutes in the dark. The mixture
was washed three times with 200 mL of hexane, and the pellet washed with 500 mL 10% trichloroacetic acid.
Heavy labeled internal standards (d4-CML) were added,remaining aqueous layer was extracted with 200 mL of
octanol. The absorbance of octanol layer was measured and the samples were hydrolyzed in 0.3 mL 6 N HCl at
1108C for 16 hours. The hydrolysates were dried underat 360 nm by a microplate-reader (SPECTRA max 250;
Molecular Devices, Sunnyvale, CA, USA). The RCO a stream of nitrogen. CML in the hydrolysates were
measured as their N,O-trifluoroacetyl methyl esters bycontent was calculated as nmol/mL using a standard
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Table 1. Results of biochemical analyses in filter- and heat-sterilized glucose, icodextrin, and amino acid peritoneal dialysis (PD) fluids
GO MGO 3-DG Total carbonyl Glucose
PD fluid g/dLlmol/L
Heat-sterilized glucose PD fluid 6.260.5 7.860.6 47.264.3 64.768.7 1.3160.03
Filter-sterilized glucose PD fluid 0.660.2b,c ,0.2 0.660.5b,d 2.060.9b,e 1.3460.04
Icodextrin PD fluid 2.661.2a 1.960.5b 4.160.7b 26.464.5a ,0.01
Amino acid PD fluid ,0.2 ,0.2 ,0.2 3.861.0b,e ,0.01
Duplicate determinaiton from three independent batches. Data are expressed as means 6 SD.
aP , 0.01 and bP , 0.001, compared with heat-sterilized glucose PD fluid
cP , 0.05, dP , 0.01, and eP , 0.001, compared with icodextrin PD fluid
selected ion-monitoring gas chromatography/mass spec- glucose, icodextrin, and amino acid PD fluids (Table 1).
trometry (GC/MS), as described previously [12]. The They are significantly lower in amino acid than in icodex-
CML and d4-CML standards [22] were gifts from Dr. trin PD fluid, both being significantly lower than in heat-
John W. Baynes. sterilized glucose PD fluids (P , 0.01). Of interest, indi-
For quantitation of pentosidine, samples (50 mL) were vidual and total RCO levels are lower in filter-sterilized
mixed with equal volume of 10% trichloroacetic acid glucose than in icodextrin PD fluid.
and centrifuged at 5000 3 g for five minutes. The super- To assess the biological significance of the various
natant was discarded, and the pellet was washed with levels of RCOs, samples of icodextrin and amino acid
300 mL of 5% trichloroacetic acid. The pellet was dried as well as heat- and filter-sterilized glucose, PD fluids
under vacuum and hydrolyzed by 100 mL of 6 N HCl were fortified with BSA and incubated for one week.
for 16 hours at 1108C under nitrogen, followed by neu- The levels of generated pentosidine and CML were mea-
tralization with 100 mL of 5 N NaOH and 200 mL of 0.5 sured as surrogate markers for AGE generation. The
mol/L phosphate buffer (pH 7.4), then filtered through
generation of pentosidine and of CML was lowest ina 0.5 mm pore filter, and diluted with phosphate-buffered
amino acid PD fluids, slightly higher in icodextrin (P ,saline (PBS). Pentosidine in these specimens was ana-
0.05) and filter-sterilized glucose PD fluid (P , 0.05),lyzed by reverse-phase HPLC according to our previous
and much higher (P , 0.001) in heat-sterilized glucosemethod [23]. Briefly, a 50 mL fluid of acid hydrolysate
PD fluid (Fig. 1).was injected into an HPLC system and separated on a
C18 reverse-phase column (Waters, Tokyo, Japan). The Effect of dwell durationeffluent was monitored using a fluorescence detector
The modification of RCOs during dwell time was in-(RF-10A; Shimadzu) and an excitation-emission wave-
vestigated. Individual RCOs fell progressively duringlength of 335/385 nm. Synthetic pentosidine [24] was
dwell time in icodextrin PD effluents (Fig. 2) but re-used to obtain a standard curve.
mained undetectable in amino acid PD effluents (data
Glucose measurement not shown). In contrast, total RCOs level rose during
Glucose was measured by a kit (Glucose CII test; the first four hours of dwell, in both fluids this increase
Wako Pure Chemicals, Osaka, Japan). This assay in- being slightly (but not significantly) higher in the icodex-
volved oxidation by glucose oxidase and mutarotation trin (Fig. 3A) than in the amino acid (Fig. 3B) PD efflu-
of glucose by aldose mutarotase. Hydrogen peroxide ents.
formed was subsequently determined in condensation Pentosidine and CML generation on BSA during incu-
reaction of 4-aminoantipyrine and phenol catalyzed by bation of icodextrin and amino acid PD effluents after
horseradish peroxidase. various dwell duration is illustrated in Figures 4 and 5.
Pentosidine generation was similar in icodextrin (Fig. 4A)Statistical analysis
and in amino acid (Fig. 4B) PD effluents after a six-hour
Data are expressed as means 6 SD. Student’s t-test or dwell time. It was significantly lower than that reportedanalysis of variance (ANOVA) was used for a statistical
previously for heat-sterilized glucose PD effluents: 163evaluation of significant variations. If a significant varia-
and 197 pmol/mL after a 5- and 12-hour dwell with heat-tion was indicated by the ANOVA, Scheffe’s test was
sterilized glucose versus 68 pmol/mL after a 6-hour dwellused to compare the values. A P value of less than 0.05
with amino acid and 64 pmol/mL after a 12-hour dwellwas considered statistically significant.
with icodextrin PD fluid. CML generation increased dur-
ing the first six-hour dwell. The rise was significantly
RESULTS greater in icodextrin (Fig. 5A) than in amino acid (Fig.
Fresh peritoneal fluids 5B) PD effluents.
The addition of aminoguanidine or OPB-9195 (50The levels of individual RCOs such as GO, MGO,
and 3-DG and of total RCOs differ markedly between mmol/L) markedly inhibited the generation of pentosi-
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Fig. 1. Generation of pentosidine (A) and
Ne-carboxymethyllysine (CML) (B) in filter-
and heat-sterilized glucose (glucose concen-
trations, 1.36%), icodextrin, and amino acid
peritoneal dialysis (PD) fluids. The contents
of pentosidine and CML generated during one
week of incubation of PD fluids fortified with
bovine serum albumin (BSA) were deter-
mined by HPLC or GC/MS. Duplicate deter-
mination from three independent batches is
shown. The amount of pentosidine or CML
generated from heat-sterilized glucose PD flu-
ids is significantly higher than that from filter-
sterilized glucose, icodextrin, and amino acid
PD fluids. Data are expressed as means 6
SD. *P , 0.001, compared with heat-sterilized
glucose PD fluids; ‡P , 0.05 and §P , 0.01,
compared with amino acid PD fluids.
Fig. 2. Kinetics of clearance of reactive carbonyl compounds (RCOs) during PD. The concentrations of glyoxal (GO; A), methylglyoxal (MGO;
B), and 3-deoxyglucosone (3-DG; C) are determined in triplicates in icodextrin PD effluents collected after various dwell times. Concentrations
fall with increasing dwell time. Data from three PD patients are expressed as means 6 SD.
dine and CML, both in the fresh fluids and in the effluents As anticipated, fresh glucose-free PD fluid contains
lower total as well as individual RCO levels than com-(Table 2).
mercial, heat-sterilized, glucose PD fluid. Incubation ex-Glucose concentration increased during dwell in both
periments confirm that these lower levels of RCOs areicodextrin and amino acid solutions, reaching values av-
associated with a lower generation of two AGE moieties,eraging 0.6 and 1.0 mg/mL, respectively, after a six-hour
CML and pentosidine. Of interest, the higher levels ofdwell. The addition of glucose during the incubation
RCOs observed in icodextrin, compared with amino acidexperiments in order to reach glucose levels of 0.50, 0.75,
solution, are matched by an enhanced in vitro production1.00, 1.25, 1.50, 1.75, and 2.00 mg/mL failed to modify
of pentosidine and CML. Recently, Barre et al havethe generation of pentosidine or CML.
reached similar conclusions for icodextrin PD fluid [25]:
AGE formation monitored by a global spectrofluoro-
DISCUSSION metric method during incubation is lower in icodextrin
To our knowledge, our observations provide the first than in heat-sterilized glucose PD fluid. Interpretation
thorough assessment of the effect of the newer glucose- of data on the RCO content and the AGE generation
free PD fluids, that is, icodextrin and amino acid, on potential of fresh PD fluid should take into account that
reactive carbonyl levels and their ability to enhance in both parameters change markedly during dwell time. We
have previously documented that in glucose dialysate,vitro AGE generation.
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Fig. 3. Kinetics of total carbonyl concentra-
tion in icodextrin (A) and amino acid (B) PD
effluents collected after various dwell times.
Data from three PD patients are expressed as
means 6 SD. *P , 0.01, compared with amino
acid PD effluents.
Fig. 4. Kinetics of pentosidine generation
during various dwell times in icodextrin (A)
and amino acid (B) PD effluents. The contents
of pentosidine generated upon incubation
of PD effluent ultrafiltrates fortified with
BSA were determined by HPLC assay. Data
from three PD patients are expressed as
means 6 SD.
Fig. 5. Kinetics of CML generation after var-
ious dwell times in icodextrin (A) and amino
acid (B) PD effluents. The contents of CML
generated upon incubation of PD effluent ul-
trafiltrates fortified with BSA were deter-
mined by GC/MS assay. Data from three PD
patients are expressed as means 6 SD. *P ,
0.05 and **P , 0.01, compared with amino
acid PD effluents.
individual RCOs such as GO, MGO, and 3-DG disap- RCOs increase with dwell time in both solutions, follow-
ing the pattern reported in glucose dialysates. However,pear rapidly, whereas total RCOs measured by the
DNPH method rise strikingly toward prevailing plasma as pointed out in the Methods section, the absence of
an adequate standard for total RCO measurement pre-levels [12]. We now document similar changes in glucose-
free dialysates. Individual RCOs such as GO, MGO, and cludes a quantitative comparison with previous results
on commercial glucose dialysates. Nevertheless, these3-DG fall progressively in icodextrin effluents or remain
undetectable in amino acid effluent. In contrast, total observations limit the extent of the advantages to be
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Table 2. Aminoguanidine or OPB-9195 inhibit pentosidine and CML formation in PD fluids and PD effluents
Pentosidine level pmol/mL CML level pmol/mL
Aminoguanidine OPB-9195 Aminoguanidine OPB-9195
Control 50 mmol/L 50 mmol/L Control 50 mmol/L 50 mmol/L
Filter-sterilized glucose PD fluid 9.3 2.5 2.1 1220 210 200
Heat-sterilized glucose PD fluid 35.2 3.7 3.4 4620 860 750
Heat-sterilized glucose PD effluent 120.1 14.4 12.5 2320 220 250
Icodextrin PD fluid 8.3 2.5 2.3 1350 250 320
Icodextrin PD effluent 70.0 9.2 7.5 2250 300 280
Amino acid PD fluid 6.4 2.4 2.1 530 110 100
Amino acid PD effluent 65.6 9.8 8.5 1250 170 190
PD fluid and effluent ultrafiltrates (after 6 hours dwell) fortified with BSA (30 mg/mL) were incubated at 378C for 1 week in 0.1 mol/L phosphate buffer (pH 7.4)
in the absence (control) or presence of either 50 mmol/L aminoguanidine or OPB-9195. Glucose PD fluids contained 1.36% glucose. The contents of pentosidine
and CML were determined in duplicate and the results averaged.
expected from the lower RCO content of glucose-free finding strongly suggests that heat sterilization generates
RCOs from icodextrin and that these RCOs contributedialysate.
The rise of RCOs during dwell probably results from to the enhanced AGE-forming potential of icodextrin
as compared with amino acids solutions.two-way exchanges [12]. GO, MGO, and 3-DG levels
fall or remain absent probably as a result of diffusion Interestingly, after dwell, CML generation but not
pentosidine generation is higher in icodextrin than inout of the peritoneal cavity. In contrast, total RCOs rise
in the peritoneal fluid presumably as a consequence of amino acid solutions, a finding compatible with the hy-
pothesis that the icodextrin-derived RCOs are precur-diffusion from elevated blood levels. A possible genera-
tion of RCOs within the peritoneal cavity cannot be sors preferentially involved in the formation of CML.
Altogether, our observations suggest that the potentialexcluded, but appears unlikely since final levels of RCOs
benefits of glucose-free solutions for the prevention ofafter a six-hour dwell are similar in icodextrin and amino
AGE formation are at least mitigated during intra-acid solutions, that is, with very different substrates.
abdominal dwell: Despite the absence of glucose, RCOsThus, total RCO influx exceeds markedly the outflux of
accumulated in uremic serum diffuse within the perito-individual RCOs.
neal cavity with an attendant increase of the AGE forma-We have at present no access to patients who are
tion potential of the dialysate. These findings do notconsistently dialyzed with glucose-free dialysate over an
detract from the clinical merits of these glucose-free PDextended period of time and are, therefore, unable to
fluids. Icodextrin fluid enhances osmotic water removalexpress any opinion on the resulting total RCO plasma
[27], and amino acid fluid improves nutrition [28]. Fur-levels. Should the latter be lower, a lower RCO content
thermore, long-term benefits of reduced PD fluid levelsof dialysate after dwell may be anticipated. Obviously,
of RCOs on the peritoneal membrane alterations remainthis will be a topic for future investigations.
unknown.The results of the incubation experiments allow for
a better assessment of the significance of changes in
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potential. Indeed, addition of glucose in the concentra- Abbreviations used in this article are: AGEs, advanced glycation
tion observed in the effluent fails to modify pentosidine end products; BSA, bovine serum albumin; CML, Ne-carboxymethyl-
lysine; 3-DG, 3-deoxyglucosone; DNPH, 2,4-dinitrophenylhydrazine;and CML formation during incubation.
GC/MS, gas chromatography/mass spectrometry; GO, glyoxal; HPLC,
Individual and total RCOs are higher in fresh icodex- high-performance liquid chromatography; MGO, methylglyoxal; PD,
peritoneal dialysis; RCO, reactive carbonyl compound.trin than in amino acid or filtered glucose solutions. This
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